Quest Diagnostics Incorporated (DGX)

NYSE: DGX · Real-Time Price · USD

239.15

+5.72 (2.45%)

At close: Oct 15, 2026, 4:00 PM EDT

239.15

0.00 (0.00%)

After-hours: Oct 15, 2026, 7:00 PM EDT

Quest Diagnostics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	26,396	19,304	16,838	15,503	17,817	21,224
Market Cap Growth	29.14%	14.64%	8.62%	-12.99%	-16.05%	32.15%
Enterprise Value	32,174	25,369	23,156	20,386	21,871	25,006
Last Close Price	233.43	170.66	145.61	130.28	144.84	157.08

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	25.40	19.54	19.44	18.24	18.91	10.68
Forward PE	20.88	17.07	15.97	15.53	18.91	18.61
PS Ratio	2.27	1.75	1.71	1.68	1.80	1.97
PB Ratio	3.42	2.65	2.44	2.42	2.97	3.23
P/FCF Ratio	19.47	14.20	18.52	17.94	13.56	11.60
P/OCF Ratio	13.80	10.24	12.62	12.19	10.37	9.51
PEG Ratio	2.13	2.04	2.42	13.49	13.49	13.49

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	2.77	2.30	2.35	2.20	2.21	2.32
EV/EBITDA Ratio	14.14	11.66	12.14	11.62	11.31	8.93
EV/EBIT Ratio	19.00	15.81	16.38	15.49	14.61	10.45
EV/FCF Ratio	23.75	18.67	25.47	23.59	16.64	13.66

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.81	0.90	1.03	0.86	0.79	0.73
Debt / EBITDA Ratio	2.31	2.49	3.08	2.61	2.07	1.53
Debt / FCF Ratio	4.75	4.85	7.83	6.36	3.59	2.61
Net Debt / Equity Ratio	0.73	0.85	0.95	0.75	0.73	0.59
Net Debt / EBITDA Ratio	2.55	2.83	3.45	2.74	2.28	1.38
Net Debt / FCF Ratio	4.28	4.54	7.23	5.57	3.35	2.11
Asset Turnover	0.70	0.68	0.65	0.69	0.75	0.78
Inventory Turnover	36.78	39.03	34.92	32.39	32.16	30.49
Quick Ratio	1.28	0.80	0.85	1.05	0.97	1.34
Current Ratio	1.59	1.04	1.10	1.31	1.22	1.56
Return on Equity (ROE)	14.60%	14.75%	13.84%	14.62%	16.15%	30.92%
Return on Assets (ROA)	6.40%	6.20%	5.86%	6.13%	7.07%	10.82%
Return on Invested Capital (ROIC)	9.54%	9.17%	8.83%	9.55%	11.41%	17.74%
Return on Capital Employed (ROCE)	11.10%	11.50%	10.10%	10.80%	13.30%	20.20%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	4.03%	5.14%	5.17%	5.51%	5.31%	9.40%
FCF Yield	5.14%	7.04%	5.40%	5.57%	7.38%	8.62%
Dividend Yield	1.44%	1.82%	1.98%	2.03%	1.65%	1.39%
Payout Ratio	36.53%	35.59%	38.00%	36.77%	32.24%	15.49%
Buyback Yield / Dilution	0.88%	-	0.89%	4.24%	7.81%	5.88%
Total Shareholder Return	2.33%	1.82%	2.87%	6.27%	9.46%	7.27%

SEC Filings: 10-K · 10-Q